Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.

Clinical trial NCT05579769 · TERMINATED

Trial details

NCT number: NCT05579769
Sponsor: St. Jude Children's Research Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic Malignancy Myeloid Malignancy

Start date: 2023-03-14
Primary completion: 2024-05-08
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.